This content is intended to be objective and factual, and for general informational purposes only. It does not express the opinions of Swisher International or any other person or entity, and does not, is not intended to, and shall not be deemed to, constitute legal advice. Further, the content presented here is intended to reflect selected, recent legislative activity only, and is expressly not a comprehensive summary of past, present, or future legislative activity within any particular geographic area or with respect to any particular subject matter. No reader, user, or browser of this site should act or refrain from acting on the basis of information on this site without first seeking legal advice from counsel in the relevant jurisdiction. Only your individual attorney can provide assurances that the information contained herein – and your interpretation of it – is applicable or appropriate to your particular situation. Use of, and access to, this website or any of the links or resources contained within the site do not create an attorney-client relationship between the reader, user, or browser and Swisher International, Inc. or its attorneys. All liability with respect to actions taken or not taken based on the contents of this site are hereby expressly disclaimed. The content on this site is provided “as is,” and no representations are made that the content is error-free.

White House Reviewing Revised FDA Guidance Document on Electronic Cigarettes

The following is an update from the National Association of Tobacco Outlets (NATO) sourced through their December 31st online bulletin. Reposted with permission.

On December 26, 2019, the FDA delivered to the White House Office of Management and Budget a revised Guidance document titled “Enforcement Priorities for Electronic Nicotine Delivery Systems and Other Deemed Products on the Market Without Premarket Authorization.”  A Guidance document explains the FDA’s current thinking on how the agency will interpret and enforce the Family Smoking Prevention and Tobacco Control Act (the law which granted the FDA the authority to regulate tobacco and vapor products).

The White House Office of Management and Budget must review and approve the Guidance document before it can be issued to the public.  As reported in November, President Trump declined to proceed with an earlier version of a FDA Guidance document related to enforcement priorities on electronic nicotine products.

The provisions in the new version of the Guidance document have not been released by the FDA or the White House and are not known at this time.  When the new Guidance document is released, NATO will report on the provisions of the Guidance.